The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
Nom du journal : Breast Cancer Res Treat
Année : 2024
Volume : 203
Page de départ : 497-509
